Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2009

01.03.2009 | Epidemiology

Changes in quality of life among breast cancer patients three years post-diagnosis

verfasst von: Wei Lu, Yong Cui, Xiaoli Chen, Ying Zheng, Kai Gu, Hui Cai, Wei Zheng, Xiao-Ou Shu

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Objectives To evaluate changes in quality of life (QOL) and identify medical and socio-demographic predictors of QOL among breast cancer survivors 3 years after diagnosis. Methods Between April 2002 and March 2004 2,232 women with breast cancer were recruited into the Shanghai Breast Cancer Survival Study, a population-based cohort study, approximately 6 months after cancer diagnosis. QOL was evaluated at 6 and 36 months post-diagnosis using the General Quality of Life Inventory. Multiple linear regression models were used to evaluate changes in QOL and their associations with socio-demographic and medical factors. Results In general, breast cancer patients showed significant improvement over time in the physical, psychological, and social well-being domains, as well as overall QOL. However, QOL scores in several facets did not improve or even deteriorated, including increased negative feelings, reduced social support and interpersonal relationships, and worsened financial situation and living environment. Age at diagnosis was inversely associated with QOL changes in physical and psychological well-being and overall QOL scores. Compared with those who were disease-free, patients with a recurrence of disease had significantly poorer QOL scores across all well-being domains and almost all facets. Patients who received radiotherapy experienced significant improvements in physical and social well-being and overall QOL. Mixed ER/PR status was associated with improved scores in physical and psychological well-being and overall QOL. Education, body mass index, Charlson comorbidity score, TNM stage, type of surgery, chemotherapy, and immunotherapy were only associated with changes in certain well-being domains and/or facets, but not overall QOL. Tamoxifen use was not associated with changes in QOL outcomes. Conclusions Our study provides valuable information for developing strategies/interventions for improving the QOL of breast cancer patients.
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
2.
Zurück zum Zitat Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66PubMedCrossRef
3.
Zurück zum Zitat Fallowfield L (2002) Quality of life: a new perspective for cancer patients. Nat Rev Cancer 2:873–879PubMedCrossRef Fallowfield L (2002) Quality of life: a new perspective for cancer patients. Nat Rev Cancer 2:873–879PubMedCrossRef
4.
Zurück zum Zitat Sun CC, Frumovitz M, Bodurka DC (2005) Quality of life and gynecologic malignancies. Curr Oncol Rep 7(6):459–465PubMedCrossRef Sun CC, Frumovitz M, Bodurka DC (2005) Quality of life and gynecologic malignancies. Curr Oncol Rep 7(6):459–465PubMedCrossRef
5.
Zurück zum Zitat American Society of Clinical Oncology Outcomes Working Group (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671–679 American Society of Clinical Oncology Outcomes Working Group (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671–679
6.
Zurück zum Zitat Movsas B (2003) Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol 13:235–247PubMedCrossRef Movsas B (2003) Quality of life in oncology trials: a clinical guide. Semin Radiat Oncol 13:235–247PubMedCrossRef
7.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe RB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe RB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
8.
Zurück zum Zitat Ferrell BR, Grant M, Funk B, Otis-Green S, Garcia N (1997) Quality of life in breast cancer. Part I: physical and social well-being. Cancer Nurs 20:398–408PubMedCrossRef Ferrell BR, Grant M, Funk B, Otis-Green S, Garcia N (1997) Quality of life in breast cancer. Part I: physical and social well-being. Cancer Nurs 20:398–408PubMedCrossRef
9.
Zurück zum Zitat Ferrell BR, Grant M, Funk B, Otis-Green S, Garcia N (1998) Quality of life in breast cancer. Part II: psychological and spiritual well-being. Cancer Nurs 21:1–9PubMedCrossRef Ferrell BR, Grant M, Funk B, Otis-Green S, Garcia N (1998) Quality of life in breast cancer. Part II: psychological and spiritual well-being. Cancer Nurs 21:1–9PubMedCrossRef
10.
12.
Zurück zum Zitat Bloom JR, Petersen DM, Kang SH (2007) Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology 16:691–706PubMedCrossRef Bloom JR, Petersen DM, Kang SH (2007) Multi-dimensional quality of life among long-term (5+ years) adult cancer survivors. Psychooncology 16:691–706PubMedCrossRef
13.
Zurück zum Zitat Bloom JR, Stewart SL, Chang S, Banks PJ (2004) Then and now: quality of life of young breast cancer survivors. Psychooncology 13:147–160PubMedCrossRef Bloom JR, Stewart SL, Chang S, Banks PJ (2004) Then and now: quality of life of young breast cancer survivors. Psychooncology 13:147–160PubMedCrossRef
14.
Zurück zum Zitat Dorval M, Maunsell E, Deschenes L, Brisson J (1998) Type of mastectomy and quality of life for long term breast carcinoma survivors. Cancer 83:2130–2138PubMedCrossRef Dorval M, Maunsell E, Deschenes L, Brisson J (1998) Type of mastectomy and quality of life for long term breast carcinoma survivors. Cancer 83:2130–2138PubMedCrossRef
15.
Zurück zum Zitat Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMed Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR (2002) Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 94:39–49PubMed
16.
Zurück zum Zitat Helgeson VS, Tomich PL (2005) Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology 14:307–317PubMedCrossRef Helgeson VS, Tomich PL (2005) Surviving cancer: a comparison of 5-year disease-free breast cancer survivors with healthy women. Psychooncology 14:307–317PubMedCrossRef
17.
Zurück zum Zitat Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L (2005) Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res 14:361–371PubMedCrossRef Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L (2005) Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res 14:361–371PubMedCrossRef
18.
Zurück zum Zitat Helgeson VS, Snyder P, Seltman H (2004) Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 23:3–15PubMedCrossRef Helgeson VS, Snyder P, Seltman H (2004) Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change. Health Psychol 23:3–15PubMedCrossRef
19.
Zurück zum Zitat Bland KI (1997) Quality-of-life management for cancer patients. CA Cancer J Clin 47:194–197PubMedCrossRef Bland KI (1997) Quality-of-life management for cancer patients. CA Cancer J Clin 47:194–197PubMedCrossRef
20.
Zurück zum Zitat Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243–250PubMedCrossRef Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243–250PubMedCrossRef
21.
Zurück zum Zitat Cui Y, Shu XO, Gao Y, Cai H, Wen W, Ruan ZX, Jin F, Zheng W (2004) The long-term impact of medical and socio-demographic factors on the quality of life of breast cancer survivors among Chinese women. Breast Cancer Res Treat 87:135–147PubMedCrossRef Cui Y, Shu XO, Gao Y, Cai H, Wen W, Ruan ZX, Jin F, Zheng W (2004) The long-term impact of medical and socio-demographic factors on the quality of life of breast cancer survivors among Chinese women. Breast Cancer Res Treat 87:135–147PubMedCrossRef
22.
Zurück zum Zitat Lu W, Cui Y, Zheng Y, Gu K, Cai H, Li Q, Zheng W, Shu XO (2007) Impact of newly diagnosed breast cancer on quality of life among Chinese women. Breast Cancer Res Treat 102:201–210PubMedCrossRef Lu W, Cui Y, Zheng Y, Gu K, Cai H, Li Q, Zheng W, Shu XO (2007) Impact of newly diagnosed breast cancer on quality of life among Chinese women. Breast Cancer Res Treat 102:201–210PubMedCrossRef
23.
Zurück zum Zitat Nuttall M, van der Meulen J, Emberton M (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59(3):265–273PubMedCrossRef Nuttall M, van der Meulen J, Emberton M (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59(3):265–273PubMedCrossRef
24.
Zurück zum Zitat Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59(3):274–280PubMedCrossRef Grunau GL, Sheps S, Goldner EM, Ratner PA (2006) Specific comorbidity risk adjustment was a better predictor of 5-year acute myocardial infarction mortality than general methods. J Clin Epidemiol 59(3):274–280PubMedCrossRef
25.
Zurück zum Zitat Department of Health, Human Services (1998) The international classification of diseases. 9th rev. edn. Clinical modification, ICD-9-CM. U.S. Government Printing Office, Washington, DC Department of Health, Human Services (1998) The international classification of diseases. 9th rev. edn. Clinical modification, ICD-9-CM. U.S. Government Printing Office, Washington, DC
26.
Zurück zum Zitat Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L (1996) Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat 38:183–199PubMedCrossRef Ganz PA, Coscarelli A, Fred C, Kahn B, Polinsky ML, Petersen L (1996) Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat 38:183–199PubMedCrossRef
27.
Zurück zum Zitat Shimozuma K, Ganz PA, Petersen L, Hirji K (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat 56:45–57PubMedCrossRef Shimozuma K, Ganz PA, Petersen L, Hirji K (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat 56:45–57PubMedCrossRef
28.
Zurück zum Zitat Janz NK, Mujahid M, Lantz PM, Fagerlin A, Salem B, Morrow M, Deapen D, Katz SJ (2005) Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res 14:1467–1479PubMedCrossRef Janz NK, Mujahid M, Lantz PM, Fagerlin A, Salem B, Morrow M, Deapen D, Katz SJ (2005) Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer. Qual Life Res 14:1467–1479PubMedCrossRef
29.
Zurück zum Zitat Bull AA, Meyerowitz BE, Hart S, Mosconi P, Apolone G, Liberati A (1999) Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat 54:47–57PubMedCrossRef Bull AA, Meyerowitz BE, Hart S, Mosconi P, Apolone G, Liberati A (1999) Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat 54:47–57PubMedCrossRef
30.
Zurück zum Zitat Frost MH, Suman VJ, Rummans TA, Dose AM, Taylor M, Novotny P, Johnson R, Evans RE (2000) Physical, psychological and social we-being of women with breast cancer: the influence of disease phase. Psychooncology 9:221–231CrossRef Frost MH, Suman VJ, Rummans TA, Dose AM, Taylor M, Novotny P, Johnson R, Evans RE (2000) Physical, psychological and social we-being of women with breast cancer: the influence of disease phase. Psychooncology 9:221–231CrossRef
31.
Zurück zum Zitat Oh S, Heflin L, Meyerowitz BE, Desmond KA, Rowland JH, Ganz PA (2004) Quality of life of breast cancer survivors after a recurrence: a follow-up study. Breast Cancer Res Treat 87:45–57PubMedCrossRef Oh S, Heflin L, Meyerowitz BE, Desmond KA, Rowland JH, Ganz PA (2004) Quality of life of breast cancer survivors after a recurrence: a follow-up study. Breast Cancer Res Treat 87:45–57PubMedCrossRef
32.
Zurück zum Zitat Northouse LL, Mood D, Kershaw T, Schafenacker A, Mellon S, Walker J, Galvin E, Decker V (2002) Quality of life of women with recurrent breast cancer and their family members. J Clin Oncol 20:4050–4064PubMedCrossRef Northouse LL, Mood D, Kershaw T, Schafenacker A, Mellon S, Walker J, Galvin E, Decker V (2002) Quality of life of women with recurrent breast cancer and their family members. J Clin Oncol 20:4050–4064PubMedCrossRef
33.
Zurück zum Zitat Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N (2002) Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef
34.
Zurück zum Zitat Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, Menard C, Lippman ME, Lichter AS, Altemus RM (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98:697–702PubMedCrossRef Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, Menard C, Lippman ME, Lichter AS, Altemus RM (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98:697–702PubMedCrossRef
35.
Zurück zum Zitat Janni W, Rjosk D, Dimpfl TH, Haertl K, Strobl B, Hepp F, Hanke A, Bergauer F, Sommer H (2001) Quality of life influenced by primary surgical treatment for stage I–III breast cancer-long-term follow-up of a matched-pair analysis. Ann Surg Oncol 8:542–548PubMed Janni W, Rjosk D, Dimpfl TH, Haertl K, Strobl B, Hepp F, Hanke A, Bergauer F, Sommer H (2001) Quality of life influenced by primary surgical treatment for stage I–III breast cancer-long-term follow-up of a matched-pair analysis. Ann Surg Oncol 8:542–548PubMed
36.
Zurück zum Zitat Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA (2000) Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 92:1422–1429PubMedCrossRef Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA (2000) Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 92:1422–1429PubMedCrossRef
37.
Zurück zum Zitat Parker PA, Youssef A, Walker S, Basen-Engquist K, Cohen L, Gritz ER, Wei QX, Robb GL (2007) Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol 14:3078–3089PubMedCrossRef Parker PA, Youssef A, Walker S, Basen-Engquist K, Cohen L, Gritz ER, Wei QX, Robb GL (2007) Short-term and long-term psychosocial adjustment and quality of life in women undergoing different surgical procedures for breast cancer. Ann Surg Oncol 14:3078–3089PubMedCrossRef
38.
Zurück zum Zitat Moyer A (1997) Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol 16:284–298PubMedCrossRef Moyer A (1997) Psychosocial outcomes of breast-conserving surgery versus mastectomy: a meta-analytic review. Health Psychol 16:284–298PubMedCrossRef
39.
Zurück zum Zitat Nissen MJ, Swenson KK, Ritz LJ, Farrell JB, Sladek ML, Lally RM (2001) Quality of life after breast carcinoma surgery: a comparison of three surgical procedures. Cancer 91:1238–1246PubMedCrossRef Nissen MJ, Swenson KK, Ritz LJ, Farrell JB, Sladek ML, Lally RM (2001) Quality of life after breast carcinoma surgery: a comparison of three surgical procedures. Cancer 91:1238–1246PubMedCrossRef
40.
Zurück zum Zitat Ganz PA, Schag AC, Lee JJ, Polinsky ML, Tan SJ (1992) Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729–1738PubMedCrossRef Ganz PA, Schag AC, Lee JJ, Polinsky ML, Tan SJ (1992) Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729–1738PubMedCrossRef
41.
Zurück zum Zitat Kagawa-Singer M, Wellisch DK, Durvasula R (1997) Impact of breast cancer on Asian American and Anglo American women. Cult Med Psychiatry 21:449–480PubMedCrossRef Kagawa-Singer M, Wellisch DK, Durvasula R (1997) Impact of breast cancer on Asian American and Anglo American women. Cult Med Psychiatry 21:449–480PubMedCrossRef
42.
Zurück zum Zitat Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst 93:979–989PubMedCrossRef Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ Jr, Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst 93:979–989PubMedCrossRef
43.
Zurück zum Zitat Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) 16:1348–1361CrossRef Janz NK, Mujahid M, Chung LK, Lantz PM, Hawley ST, Morrow M, Schwartz K, Katz SJ (2007) Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) 16:1348–1361CrossRef
44.
Zurück zum Zitat Hickok JT, Morrow GR, Roscoe JA, Mustian K, Okunieff P (2005) Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage 30:433–442PubMedCrossRef Hickok JT, Morrow GR, Roscoe JA, Mustian K, Okunieff P (2005) Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage 30:433–442PubMedCrossRef
45.
Zurück zum Zitat Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial Ontario Clinical Oncology Group. Cancer 88:2260–2266PubMedCrossRef Whelan TJ, Levine M, Julian J, Kirkbride P, Skingley P (2000) The effects of radiation therapy on quality of life of women with breast carcinoma: results of a randomized trial Ontario Clinical Oncology Group. Cancer 88:2260–2266PubMedCrossRef
46.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351:1451–1467CrossRef Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 351:1451–1467CrossRef
47.
Zurück zum Zitat Whelan TJ, Pritchard KI (2006) Managing patients on endocrine therapy: focus on quality-of-life issues. Clin Cancer Res 12:1056–1060CrossRef Whelan TJ, Pritchard KI (2006) Managing patients on endocrine therapy: focus on quality-of-life issues. Clin Cancer Res 12:1056–1060CrossRef
48.
Zurück zum Zitat Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A (2004) Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22:4261–4271PubMedCrossRef Fallowfield L, Cella D, Cuzick J, Francis S, Locker G, Howell A (2004) Quality of life of postmenopausal women in the arimidex, tamoxifen, alone or in combination (ATAC) adjuvant breast cancer trial. J Clin Oncol 22:4261–4271PubMedCrossRef
49.
Zurück zum Zitat Fallowfield LJ, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coombes RC, Hall E (2006) Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 24:910–917PubMedCrossRef Fallowfield LJ, Bliss JM, Porter LS, Price MH, Snowdon CF, Jones SE, Coombes RC, Hall E (2006) Quality of life in the intergroup exemestane study: a randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 24:910–917PubMedCrossRef
50.
Zurück zum Zitat Vacek PM, Winstead-Fry P, Secker-Walker RH, Hooper GJ, Plante DA (2003) Factors influcing quality of life in breast cancer survivors. Qual Life Res 12:527–537PubMedCrossRef Vacek PM, Winstead-Fry P, Secker-Walker RH, Hooper GJ, Plante DA (2003) Factors influcing quality of life in breast cancer survivors. Qual Life Res 12:527–537PubMedCrossRef
51.
Zurück zum Zitat Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D (2003) Predictors of quality of life pf breast cancer patients. Acta Oncol 42:710–718PubMedCrossRef Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Holzel D (2003) Predictors of quality of life pf breast cancer patients. Acta Oncol 42:710–718PubMedCrossRef
52.
Zurück zum Zitat Härtl K, Janni W, Kästner R, Sommer H, Strobl B, Rack B, Stauber M (2003) Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol 14:1064–1071PubMedCrossRef Härtl K, Janni W, Kästner R, Sommer H, Strobl B, Rack B, Stauber M (2003) Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients. Ann Oncol 14:1064–1071PubMedCrossRef
53.
Zurück zum Zitat Browall MM, Ahlberg KM, Persson LO, Karlsson PO, Danielson EB (2008) The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy. Acta Oncol 47(2):207–215PubMedCrossRef Browall MM, Ahlberg KM, Persson LO, Karlsson PO, Danielson EB (2008) The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy. Acta Oncol 47(2):207–215PubMedCrossRef
54.
Zurück zum Zitat Fehlauer F, Tribius S, Mehnert A, Rades D (2005) Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy. Breast Cancer Res Treat 92:217–222PubMedCrossRef Fehlauer F, Tribius S, Mehnert A, Rades D (2005) Health-related quality of life in long term breast cancer survivors treated with breast conserving therapy: impact of age at therapy. Breast Cancer Res Treat 92:217–222PubMedCrossRef
Metadaten
Titel
Changes in quality of life among breast cancer patients three years post-diagnosis
verfasst von
Wei Lu
Yong Cui
Xiaoli Chen
Ying Zheng
Kai Gu
Hui Cai
Wei Zheng
Xiao-Ou Shu
Publikationsdatum
01.03.2009
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2009
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0008-3

Weitere Artikel der Ausgabe 2/2009

Breast Cancer Research and Treatment 2/2009 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.